截止2025年9月30日，公司对七乐康数字医疗投资的账面价值为3.26亿元，石榴云医于2025年10月8日在 美国纳斯达克IPO上市，发行价为4.00美元/股。截至2025年12月31日收盘价为0.2949美元/股，按当日美 元汇率中间价换算为2.0728元/股，考虑限售折扣后，公司持有对应股权的市值为3,307.91万元，公司应 确认公允价值变动损益-2.93亿元。 蓝鲸新闻1月7日报道《步长制药陷存货危机：45亿库存压仓，5.5亿纠纷未解，销售费高企研发乏力》 显示，步长制药在公告中明确指出，该诉讼事项法院已立案受理，尚未开庭审理，案件的最终结果存在 不确定性，涉及5.5亿元左右存货存在计提存货跌价准备的风险，对该公司本期利润及期后利润影响金 额尚不能确定。涉诉库存仅占其存货总量的12%左右，截至2025年三季度末，该公司存货已达45.17亿 元。 中国经济网北京1月9日讯大河财立方1月6日报道《短短3个月浮亏90%！步长制药（603858）"踩雷"美 股损失近3亿》显示，山东步长制药股份有限公司发布公告，公司对广州七乐康数字健康医疗科技有限 公司的投资，2025年预计确认公允价值变动损益-2.93亿元。 ...

| 代码 | 名称 | 最新价 | 涨跌幅 √ | 涨跌额 | 成交额 | | --- | --- | --- | --- | --- | --- | | STEC | 三合智能 | 1.5300 | 59.38% | +0.5700 | 3107.75万 | | HIHO | 骇维金属加工 | 1.2500 | 50.60% | +0.4200 | 2.61亿 | | POM | 石榴云医 | 0.3499 | 30.95% | +0.0827 | 323.61万 | | NAMI | 进馨科技 | 0.8098 | 22.53% | +0.1489 | 11.2万 | | XHG | XChange TEC | 1.1200 | 22.10% | +0.2027 | 10.31万 | 格隆汇12月24日｜中概股收盘涨幅居前的个股为：三合智能涨59.38%，骇维金属加工涨50.6%，石榴云 医涨30.95%，进馨科技涨22.53%，XChange TEC涨22.1%。(格隆汇) ...

Group 1 - The core point of the article highlights significant declines in the stock prices of several Chinese concept stocks, with 东方文化 experiencing the largest drop of 89.53% [1] - 东方文化's latest price is 0.911, with a decrease of 7.789 and a trading volume of 46.57 million [1] - 明珠货运 saw a decline of 61.57%, with its latest price at 0.0216, a drop of 0.0346, and a trading volume of 3.96 million [1] - ChowChow Cloud Inte's stock fell by 38.80%, with a current price of 1.120, a decrease of 0.710, and a trading volume of 9.92 million [1] - 逸仙电商's stock price decreased by 30.91%, currently at 3.890, down by 1.740, with a trading volume of 6.13 million [1] - 石榴云医 experienced a decline of 23.12%, with a latest price of 0.3844, a drop of 0.1156, and a trading volume of 4.69 million [1]

Group 1 - The article highlights significant declines in the stock prices of several Chinese concept stocks, with Wok Medical dropping by 96.59% and Pomegranate Cloud Medical by 90.77% [1] - ChowChow Cloud Inte experienced a decline of 84.36%, while Reto Eco fell by 34.15% and Zhongchi Chefu decreased by 26.37% [1] - The trading volumes for these stocks were notable, with Wok Medical having a transaction amount of 40.03 million and Pomegranate Cloud Medical at 28.88 million [1]

Core Insights - The market has experienced significant price movements among several companies, with notable declines in stock values, indicating a critical reassessment of their market positions [1][7] Company Summaries - WORK Medical Technology Group Ltd. (NASDAQ:WOK) saw a dramatic stock price decrease of 96.00% to $0.22, despite its subsidiary securing a $114,000 service contract, with trading volume reaching 75,256,805 [2][8] - Agape ATP Corporation (NASDAQ:ATPC) experienced a 95.09% drop in stock price to $0.06, even with a strategic partnership involving a purchase order for EN590 diesel and Jet Fuel A1, and a trading volume of 81,386,239 [3][8] - POMDOCTOR Ltd. (NASDAQ:POM) reported an 89.11% decline in stock price to $0.59, following the release of its unaudited financial results for the first half of fiscal 2025, indicating challenges in balancing expansion and operational discipline [4][8] - ChowChow Cloud International Ho (NYSE American:CHOW) saw an 87.69% decrease in stock price to $1.44 after closing its IPO, raising nearly $12 million, with a significant drop from a year-high of $21.91 [5] - Aimei Health Technology Co., Ltd (Symbol: AFJK) experienced a 62.15% decrease in stock price to $33.5, following a dramatic surge and subsequent decline in after-hours trading, reflecting notable market adjustments [6]

**POMDOCTOR LIMITED****UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS**||||||**December 31,2024**|||**June 30,2025**|||**June 30,2025**||||**RMB**|||**RMB**|||**US$**||**Assets**||||||||||Current assets:||||||||||Cash and cash equivalents (including amounts of the consolidated VIEs ofRMB7,596,708 and RMB5,579,802 (US$778,910) as of December 31,2024 and June 30, 2025, respectively)|||7,651,695||||5,746,989||||802,249||Accounts receivable, net (including amounts of the consolidated VIEs ofRMB8,374,608 and RM ...

Group 1 - The core point of the article highlights significant declines in the stock prices of several Chinese concept stocks, with notable drops in their trading volumes and market performance [1] Group 2 - KXIN (KXIN Auto) experienced a drastic decline of 62.36%, closing at 0.455 with a drop of 0.755 and a trading volume of 9.4727 million [1] - EPWK (Yipin Weike) saw a decrease of 38.10%, closing at 0.0403 with a drop of 0.0248 and a trading volume of 1.4236 million [1] - WXM (Shanyou International) fell by 22.02%, closing at 0.4600 with a drop of 0.1299 and a trading volume of 1.3871 million [1] - POM (Shiliu Yunyi) dropped by 20.80%, closing at 3.580 with a drop of 0.940 and a trading volume of 9.5167 million [1] - YGMZ (Mingzhu Freight) decreased by 17.76%, closing at 1.250 with a drop of 0.270 and a trading volume of 0.361 million [1]

Group 1 - The article reports significant declines in the stock prices of several Chinese concept stocks, with Kuke Music experiencing the largest drop of 62.49% [1] - Other notable declines include Paiming Xincheng down 20.86%, BQ Pets down 17.31%, Wu Xin Holdings down 16.86%, and Shiliu Yunyi down 14.72% [1] - The trading volumes for these stocks varied, with Kuke Music having a trading volume of 51,300, while Shiliu Yunyi had a higher volume of 6,585,000 [1]

Group 1 - Citi Issuer Services, through Citibank, N.A., has been appointed as the Depositary Bank for POMDOCTOR LIMITED's American Depositary Receipt (ADR) program [1] - POMDOCTOR LIMITED is a Chinese online medical services platform [1] - The American Depositary Shares (ADS) of POM trade on the Nasdaq Stock Exchange under the ticker "POM" [1] Group 2 - Each six (6) ADSs represent one (1) Class A ordinary share of POM [1] - The initial public offering price is set at US$4.00 per ADS [1] - The total offering details are not specified in the provided content [1]

Group 1 - The core viewpoint of the article highlights the successful IPO of the mobile healthcare platform, Shiliu Yunyi, on NASDAQ under the ticker "POM," raising $20 million by issuing 5 million shares at $4 each, marking it as the first Chinese company to go public in the U.S. in October 2023 [1] - On its first trading day, Shiliu Yunyi opened at $4.5, a 12.5% increase from the issue price, reaching a peak of $5.04 during the day, and closing at $4.03, a slight increase of 0.75%, with a total market capitalization of approximately $477 million [1] Group 2 - Shiliu Yunyi focuses on chronic disease management, creating a "doctor-pharmacy-patient" service platform that provides comprehensive services such as patient management, electronic medical record creation, follow-up care, and medication recommendations, aimed at enhancing the efficiency of medical resource flow and service delivery [3] - The company has established a strong market position in chronic disease management, ranking sixth in China's internet hospital market based on the number of contracted doctors, with over 212,800 contracted doctors and 699,000 patients served by the end of 2024, achieving a remarkable doctor retention rate of 99.5% and issuing approximately 3.13 million prescriptions in 2024 [6] Group 3 - The funds raised from the IPO will primarily be used for supply chain inventory, expanding business and geographic coverage, technology research and development, and general working capital [8] - Post-IPO, the company's ownership structure remains concentrated, with founder Shi Zhenyang holding 29% of the shares and 76% of the voting rights, ensuring absolute control over the company, while other major shareholders include Dan Hong (H.K.) Technology Limited (15% share, 5.1% voting rights), Nova Compass Investment Limited (9.9% share, 3.3% voting rights), and Beijing Gaotejia Technology Partnership (6.9% share, 2.3% voting rights) [8]